Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cibus, Inc.CLXT · Entity 6658 | 10% owner | October 16, 2020 | October 20, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cibus, Inc.
Report date October 16, 2020 · Filed October 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,963,175 |
Reported balance
After 2020-10-16 transaction · row 1
1 source rowRow 1 · 2020-10-16 · Other · Acquired 1,250,000 · Balance 23,963,175 F1: Purchased directly from Calyxt, Inc. in Calyxt, Inc.'s direct offering pursuant to a registration statement on Form S-3 (333-233231). The shares of common stock were purchased at the offering price. |
Filing footnotes · ownership attribution and instrument terms
F1: Purchased directly from Calyxt, Inc. in Calyxt, Inc.'s direct offering pursuant to a registration statement on Form S-3 (333-233231). The shares of common stock were purchased at the offering price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2020 Filed Oct 20, 2020 10:05 UTC | Cibus, Inc. CLXT · Entity 6658 | OtherCommon Stock | 1,250,000 | $4.00 | $5,000,000.00 |
DisclosureSEC source: 0000899243-20-028665 · doc4.xml · nonDerivative · entry 1 Cellectis S.A. · CIK 0001627281 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,963,175 F1 · kind: Purchased directly from Calyxt, Inc. in Calyxt, Inc.'s direct offering pursuant to a registration statement on Form S-3 (333-233231). The shares of common stock were purchased at the offering price. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 18:19 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 63,175 | $19.49 | $1,231,280.75 |
DisclosureSEC source: 0001127602-18-021023 · form4.xml · nonDerivative · entry 1 Cellectis S.A. · CIK 0001627281 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,713,175 F1 · shares: These shares were purchased pursuant to Share Purchase Agreements, dated June 13, 2018, from individuals with Restricted Stock Units of Calyxt, Inc. vesting on June 14, 2018 at the closing price of the shares on The Nasdaq Global Market on June 14, 2018. The reporting person undertakes to provide the staff of the SEC, upon request, full information regarding the number of shares purchased from each individual. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:31 UTC | Cibus, Inc. CLXT · Entity 6658 | OtherCommon Stock | 550,000 | $15.00 | $8,250,000.00 |
DisclosureSEC source: 0000899243-18-013568 · doc4.xml · nonDerivative · entry 1 Cellectis S.A. · CIK 0001627281 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,650,000 F1 · kind: Purchased directly from Calyxt, Inc. in Calyxt, Inc.'s public offering pursuant to the registration statements on Form S-1 (333-224945 and 333-225017). The shares of common stock were purchased at the public offering price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.